Pharvaris-funded HAE management analysis flags treatment satisfaction gaps
PHVS•Pharvaris reported publication of a funded real-world analysis in Advances in Therapy that found gaps between guideline-recommended hereditary angioedema care and routine practice, with treatment burden shaping satisfaction and switching decisions.
1. Study findings
Many patients did not treat every attack, often citing perceived low severity or practical barriers related to injectable therapies. Patient feedback favored daily oral prevention over intermittent injections.
